Simulation of dosing suggests that while older children (10-17 years of age) will have serum levels close to those seen in adults, younger children will have appreciably lower levels.
See tähendab, et vanematel lastel (10… 17- aastastel) on ravimi seerumitasemed sarnased täiskasvanutega, kuid madalamad väikelastel.